TerminatedNot Applicable

Time for a Paradigm Shift: STEMI/NSTEMI to OMI/NOMI ?

Stopped: Problems due to retrospective data acquisition

Turkey (Türkiye)2,500 participantsStarted 2020-09-01

Plain-language summary

The current ST-segment elevation (STEMI)/non-STEMI treatment paradigm misses nearly one fourth of acute coronary occlusions (ACO) that needs immediately reperfusion. Many of these cases can be recognized by subtle changes on ECG, but the current STEMI criteria do not include them. The investigators of this research believe a new occlusive/non-occlusive myocardial infarction (OMI/NOMI) approach will be superior to the established STEMI/non-STEMI paradigm in early detection of ACO, limiting infarct size, reducing re-hospitalizations and most important of all, reducing mortality.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical picture compatible with acute coronary syndrome AND recognized as OMI/STEMI (according to the treating provider) or cardiac high-sensitive troponins levels are elevated Exclusion Criteria: * Unable to acquire ECG

What they're measuring

Mortality

Timeframe: One year

Mortality in OMI (+) but STEMI (-) patients

Timeframe: One year

Trial details

NCT IDNCT05705102

SponsorMarmara University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Myocardial Infarction trials